E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

2016 Press Releases

This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.

Keyword Search
 
2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006
DateTitle 
08/18/16Quest Diagnostics Approved to Use Electronic Drug Test Process for Federally-Mandated Workforce by U.S. Health and Human Services
eCCF dramatically improves efficiency and time savings in workplace drug testing MADISON, N.J., Aug. 18, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic services, announced today that the U.S. Department of Health and Human Services (HHS) has authorized the company to perform drug testing using electronic Custody and Control Forms (eCCF) for federally-mandated, safety-sensitive workers. With the approval, Quest becomes the largest workplace dru... 
Printer Friendly Version
08/17/16Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., Aug. 17, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.40 per share, payable on October 19, 2016 to shareholders of record of Quest Diagnostics common stock on October 4, 2016. About Quest Diagnostics Quest Diagnostics empowers people to take action to improve health outcomes.  Derived from the world's largest database of... 
Printer Friendly Version
08/05/16Quest Diagnostics To Speak At The 18th Annual Pacific Crest Global Technology Leadership Forum
MADISON, N.J., Aug. 5, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 18th Annual Pacific Crest Global Technology Leadership Forum in Vail, Colorado. Lidia Fonseca, the company's Senior Vice President and CIO, will discuss the company's technology solutions and the role of technology within the organization. The presentation is scheduled for Tuesday, August 9th, 2016 ... 
Printer Friendly Version
08/05/16Quest Diagnostics To Speak At The Canaccord Genuity 36th Annual Growth Conference
MADISON, N.J., Aug. 5, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Canaccord Genuity 36th Annual Growth Conference in Boston, Massachusetts. Mark Guinan, the company's Senior Vice President and CFO, will discuss the company's vision, goals and five point strategy. The presentation is scheduled for Wednesday, August 10, 2016 at 10:00 a.m. Eastern Time. The pres... 
Printer Friendly Version
08/04/16Quest Diagnostics Launches New Digital Dementia Assessment Test to Aid Physicians' Assessment of Individuals with Cognitive Dysfunction
First digital testing technology from diagnostics leader is designed to help primary care physicians and ACOs improve the detection and monitoring of patients with dementias such as Alzheimer's disease MADISON, N.J., Aug. 4, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced CogniSense™, a digital cognitive assessment tool that aids in a physician's assessment, diagnosis and care management of individuals with... 
Printer Friendly Version
08/03/16Quest Diagnostics and AncestryDNA Collaborate to Expand Consumer DNA Testing
World leaders in consumer genomics and diagnostic information services team up Driven by rapidly growing global consumer demand for self-discovery through genomics MADISON, N.J., and LEHI, Utah, Aug. 3, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and AncestryDNA, the leader in family history and consumer genomics, are teaming up to help meet the rapidly growing consumer demand for genetic tests that provide insights... 
Printer Friendly Version
07/27/16Data Diagnostics Healthcare Technology Wins Two Gold Honors for Innovation in the 2016 Golden Bridge Awards
Healthcare analytics technology from Quest Diagnostics and Inovalon supports adoption of value-based care MADISON, N.J., July 27, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) today announced that Data Diagnostics™, a point-of-care health analytics technology, has won two gold medals at the 2016 Golden Bridge Awards. The solution earned gold in the categories of New Product, Service, Upgrade, or Innovation of the Year and Innovations in Technology. The annua... 
Printer Friendly Version
07/26/16One in Two American Adults Misuse Their Prescription Drugs, Finds Analysis of More Than Three Million Lab Tests from Quest Diagnostics
Study Finds Sharp Increase in Patients Who Combine Prescribed Medications with Other Drugs; Two in Three Users of Heroin Take it with Benzodiazepines, a Potentially Lethal Combination MADISON, N.J., July 26, 2016 /PRNewswire/ -- The majority of American adults taking opioids and other commonly prescribed medications use them in ways that put their health at risk, including potentially dangerous combinations with other drugs, according to a new study from Quest Diagnostics (NYSE: DGX), the w... 
Printer Friendly Version
07/21/16Quest Diagnostics Reports Second Quarter 2016 Financial Results
- Q2 2016 revenues of $1.91 billion, lower by 1% on a reported basis and higher by 2.4% on an equivalent basis versus 2015 - Reported diluted EPS of $1.37, up 69.1% from 2015 - Adjusted diluted EPS excluding amortization of $1.34, up 7.2% from 2015 - Updates full year reported EPS guidance and maintains full year adjusted outlook MADISON, N.J., July 21, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, ... 
Printer Friendly Version
06/30/16Quest Diagnostics To Release Second Quarter 2016 Financial Results On July 21
MADISON, N.J., June 30, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2016 financial results on Thursday, July 21, 2016, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can be accessed in listen-only mode by dialing 773-681-5898, passcode 3214469. The co... 
Printer Friendly Version
06/15/16Unsafe Lead Levels in Children Found in Numerous Regions of the United States, Finds New Study in Journal of Pediatrics
Largest percentage of children with very high blood lead levels concentrated in six regions, including in New York, Pennsylvania and Ohio MADISON, N.J., June 15, 2016 /PRNewswire/ -- Despite four decades of public health efforts to minimize children's exposure to lead, high percentages of unsafe blood lead levels are still found in children in numerous regions of the United States, according to a new study by researchers at Quest Diagnostics (NYSE: DGX), the world's leading provider of diag... 
Printer Friendly Version
06/15/16Quest Diagnostics and Safeway Team to Offer Convenient Diagnostic Testing to Customers in More States
MADISON, N.J., June 15, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Safeway, one of the largest food and drug retailers in the U.S., are teaming up to offer diagnostic testing in 12 Safeway locations, in addition to the two locations currently operating in Arizona through Quest's Sonora Quest Laboratories joint venture with Banner Health.   Quest Diagnostics will provide diagnostic testing services offered in comp... 
Printer Friendly Version
06/14/16New Study of Physicians and Health Plan Executives Reveals Actions Needed to Accelerate Value-Based Care
HIGHLIGHTS FROM THE QUEST DIAGNOSTICS/INOVALON STUDY INCLUDE: - Seventy-four percent of physicians and health plan executives said that quality measures are too complex, making it difficult for physicians to achieve them. - About two-thirds (65 percent) of physicians said they do not have all the healthcare information they need about their patients. - Sixty-four percent of physicians and health plan executives said that physicians do not have the tools needed to succeed in a value-base... 
Printer Friendly Version
06/09/16Data Diagnostics Healthcare Technology Wins Two 2016 IT World Awards
Healthcare analytics technology from Quest Diagnostics and Inovalon connects with nearly 600 EHR platforms to provide actionable patient insights at the point of care MADISON, N.J., June 9, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) today announced that Data Diagnostics™, a point-of-care health analytics technology, has won two IT World Awards®. The solution earned a gold medal in the IT Products and Services for Healthcare category and a bronze medal for... 
Printer Friendly Version
06/06/16Quest Diagnostics to Relocate Corporate Headquarters, Consolidate Office Facilities, in New Jersey
MADISON, N.J., June 6, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, will relocate its corporate headquarters from Madison, N.J. to Secaucus, N.J. when its lease expires in September 2017.  The company also will consolidate its corporate support functions in Lyndhurst, N.J. with the new headquarters in Secaucus upon expiration of its current lease of that facility, also in September 2017. The new office loc... 
Printer Friendly Version
06/02/16Quest Diagnostics To Speak At The Goldman Sachs 37th Annual Global Healthcare Conference
MADISON, N.J., June 2, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Goldman Sachs 2016 Global Healthcare Conference in Rancho Palos Verdes, California. Mark Guinan, the company's Senior Vice President and CFO, will discuss the company's vision, goals and five point strategy. The presentation is scheduled for Tuesday, June 7, 2016 at 11:40 a.m. Eastern Time. The... 
Printer Friendly Version
06/02/16Fit Female College Athletes More Prone to Overreaching than Less Fit Ones, Putting Performance at Risk, Finds New Research Presented at American College of Sports Medicine Annual Meeting
Biomarker monitoring may help identify athletes at risk for overtraining BOSTON and MADISON, N.J., June 2, 2016 /PRNewswire/ -- Female college athletes at their highest pre-season fitness levels may be more susceptible to overreach in a team sport environment than less fit ones, according to original research being presented at the American College of Sports Medicine Annual (ACSM) Meeting. Researchers at Rutgers, The State University of New Jersey, reported that biomarker testing of fe... 
Printer Friendly Version
06/01/16One Year After Launch, BRCA Share™ Open Data Initiative Reveals New Findings on BRCA Gene Mutations Linked to Hereditary Breast and Ovarian Cancer Risk
Co-Founded by Quest Diagnostics and Inserm, with LabCorp as First Member, BRCA Share is now the Largest Open BRCA Datashare of Curated BRCA Variants Clinically Suitable for Patient Management MADISON, N.J. and PARIS and BURLINGTON, N.C., June 1, 2016 /PRNewswire/ -- BRCA Share, a public-private BRCA gene datashare initiative, today announced the public release of a large collection of new data on genetic variants in the BRCA1 and BRCA2 genes. Mutations of these genes raise the risk of breas... 
Printer Friendly Version
05/31/16Quest Diagnostics and HCA's HealthONE System Partner to Deliver High-Value and Innovative Laboratory Services at Six Denver-Area HealthONE Hospitals
MADISON, N.J. and DENVER, May 31, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and the HealthONE System of HCA Healthcare (NYSE: HCA) are teaming up to enhance the quality and value of diagnostic services to patients and their doctors through an agreement for Quest to manage in-patient laboratory operations for six Denver-area hospitals in the HealthONE system.  Under the agreement, Quest Diagnostics will manage Health... 
Printer Friendly Version
05/26/16Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk
34-gene panel for assessing risk of 15 inherited cancers among new Quest Vantage™ test services to be highlighted during the 2016 ASCO Annual Meeting MADISON, N.J., May 26, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of three new cancer test services designed to provide clinically actionable insight into an individual's risk of developing hereditary forms of cancer.  Part of the company... 
Printer Friendly Version
05/23/16Quest Diagnostics Announces Proposed Senior Notes Offering
MADISON, N.J., May 23, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it intends to offer $500,000,000 aggregate principal amount of senior notes in a public offering made under a shelf registration statement filed with the Securities and Exchange Commission, subject to market and other conditions. The issuance of the notes will be subject to customary closing conditions. The company int... 
Printer Friendly Version
05/18/16Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., May 18, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.40 per share, payable on July 20, 2016 to shareholders of record of Quest Diagnostics common stock on July 6, 2016. About Quest Diagnostics Quest Diagnostics empowers people to take action to improve health outcomes.  Derived from the world's largest database of clinic... 
Printer Friendly Version
05/18/16Quest Diagnostics Completes Effort to Refocus on Diagnostic Information Services; Updates 2016 Revenue Outlook
- Strategy to refocus business portfolio completed with sale of Focus Diagnostics products business for $300 million - Full Year 2016 revenue now expected to be between $7.47 billion and $7.54 billion, reflecting sale - Full year 2016 EPS outlook remains unchanged MADISON, N.J., May 18, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed efforts to refocus its business on diagnostic ... 
Printer Friendly Version
05/13/16DiaSorin S.p.A. Completes Acquisition of the Focus Diagnostics' Molecular and Immunoassay Product Business from Quest Diagnostics
SALUGGIA, Italy, May 13, 2016 /PRNewswire/ -- DiaSorin S.p.A. (FTSE Italy: DIA) today announced the completion of the transaction to acquire the Focus Diagnostics' immunodiagnostic and molecular diagnostic products business ("Focus") from Quest Diagnostics (NYSE: DGX), initiated with a binding purchase agreement signed on March 29, 2016. DiaSorin paid to Quest Diagnostics $300 million in cash for all the tangible and intangible assets of Focus used by the latter to develop, manufacture and... 
Printer Friendly Version
04/28/16Zika Test from Quest Diagnostics Authorized by the FDA for Emergency Use
First Test from a Commercial Lab to Receive Emergency Use Authorization for Testing Patients in the United States, including Puerto Rico, for Zika Infection MADISON, N.J., April 28, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received a U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the Zika Virus RNA Qualitative Real-Time RT-PCR test (Zika RT-PCR test). The te... 
Printer Friendly Version
04/21/16Quest Diagnostics Reports First Quarter 2016 Financial Results
- Q1 2016 revenues of $1.86 billion grew 3.6% on an equivalent basis and 1.3% on a reported basis - Diagnostic Information Services revenues increased 3.8% from a year ago - Adjusted diluted EPS excluding amortization of $1.12, up 6.7% from 2015 - Reported diluted EPS of $0.70, up 67% from 2015 MADISON, N.J., April 21, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that for the first ... 
Printer Friendly Version
04/15/16New Diagnostic Pathways Could Improve Dementia Diagnosis, According to Consensus Statements to Be Presented at the American Academy of Neurology Annual Meeting
Quest Diagnostics and UCSF will also present novel research on improving the quality and reducing the costs of dementia care MADISON, N.J., April 15, 2016 /PRNewswire/ -- A tiered diagnostic approach that incorporates clinical, imaging and laboratory data may help physicians more efficiently screen for neurodegenerative disorders such as dementia, according to the consensus of a multi-disciplinary panel of experts. The consensus statement is among eight presentations developed with the part... 
Printer Friendly Version
04/14/16Quest Launches New Hepatitis C Virus Test Capabilities for Recently FDA-approved Antiviral Therapies
MADISON, N.J., April 14, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has expanded its chronic hepatitis C virus (HCV) test services to include new capabilities to help physicians identify or predict resistance to several HCV therapies, including the recently FDA-approved Zepatier™, from Merck, and Daklinza™, from Bristol-Myers Squibb. The new services enhance the ability of physicians to determ... 
Printer Friendly Version
04/07/16Quest Diagnostics To Release First Quarter 2016 Financial Results On April 21
MADISON, N.J., April 7, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2016 results on Thursday, April 21, 2016, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can be accessed in listen-only mode by dialing 773-681-5898, passcode 3214469. The company sugg... 
Printer Friendly Version
03/30/16DiaSorin To Acquire Focus Diagnostics' Molecular And Immunoassay Product Business From Quest Diagnostics, Significantly Advancing Its Presence In The Molecular Diagnostic Market
- Focus Diagnostics' unique Simplexa™ platform and products to allow DiaSorin to quickly enter the molecular segment; - DiaSorin will strengthen its offering in the US market accessing approximately 200 hospitals served today by Focus, and will leverage its commercial presence worldwide to distribute the Focus products in markets today under served in Europe and Asia; - The cash transaction, valued at $300 million, is expected to be immediately accretive to DiaSorin's ongoing earnings per ... 
Printer Friendly Version
03/29/16Quest Diagnostics Marlborough Lab Earns LEED Green Building Certification
MADISON, N.J., March 29, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that its state of the art clinical laboratory in Marlborough, Mass., has achieved Leadership in Energy and Environmental Design (LEED) certification from  the U.S. Green Building Council. The 209,000 square foot lab serves as the hub for the New England area and hosts more than 1,000 employees. Environmentally friendly features ... 
Printer Friendly Version
03/29/16Quest Diagnostics Announces Early Tender Date Results of Cash Tender Offers for Up to $200 Million Combined Aggregate Principal Amount of Certain of its Outstanding Notes
MADISON, N.J., March 29, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the early tender results of its previously announced cash tender offers (each, an "Offer" and, collectively, the "Offers") to purchase up to $200 million combined aggregate principal amount (the "Maximum Tender Amount") of its 6.950% Senior Notes due 2037 (the "2037 Notes") and 5.750% Senior Notes due 2040 (the "2040 Notes" and... 
Printer Friendly Version
03/28/16Quest Diagnostics Announces Pricing of Cash Tender Offers for Up to $200 Million Combined Aggregate Principal Amount of Certain of its Outstanding Notes
MADISON, N.J., March 28, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the determination of the pricing for its previously announced cash tender offers (each, an "Offer" and, collectively, the "Offers") to purchase up to $200 million combined aggregate principal amount (the "Maximum Tender Amount") of its 6.950% Senior Notes due 2037 (the "2037 Notes") and 5.750% Senior Notes due 2040 (the "2040 N... 
Printer Friendly Version
03/15/16Quest Diagnostics Commences Cash Tender Offer for Up to $200 Million Combined Aggregate Principal Amount of Certain of its Outstanding Notes
MADISON, N.J., March 15, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has commenced cash tender offers (each, an "Offer" and, collectively, the "Offers") to purchase up to $200 million combined aggregate principal amount (the "Maximum Tender Amount") of its 6.950% Senior Notes due 2037 and 5.750% Senior Notes due 2040 (collectively, the "Notes"). The terms and conditions of the Offers are... 
Printer Friendly Version
03/09/16Quest Diagnostics To Speak At The Barclays Global Healthcare Conference
MADISON, N.J., March 9, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Barclays Global Healthcare Conference in Miami.  Mark Guinan, the company's Senior Vice President and CFO, will discuss the company's vision, goals and five point strategy. The presentation is scheduled for Thursday, March 17, 2016 at 10:45 a.m. Eastern Time. The presentation will be webcast l... 
Printer Friendly Version
02/29/16Quest Diagnostics Completes Acquisition of Clinical Laboratory Partners' Outreach Laboratory Service Business in Connecticut
MADISON, N.J. and HARTFORD, Conn., Feb. 29, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of the outreach laboratory service business of Clinical Laboratory Partners (CLP), a wholly-owned subsidiary of Hartford HealthCare (HHC). HHC is an integrated health care system with five hospitals in Connecticut. Financial terms were not disclosed. With the acq... 
Printer Friendly Version
02/24/16Quest Diagnostics and Inovalon Bring Real-Time, Point-of-Care Analytics to HIMSS16 with Data Diagnostics™
Integrated with nearly 600 EHR platforms to align clinical management with quality, utilization and financial performance goals MADISON, N.J. and BOWIE, M.D., February 24, 2016 – Quest Diagnostics (NYSE: DGX) and Inovalon (Nasdaq: INOV) today announced they will showcase Data Diagnostics™, real-time analytics at the point of care, at HIMSS16, furthering the national roll-out of the solution. Based on one of healthcare’s largest datasets and integrated with nearly 600 electronic h... 
Printer Friendly Version
02/22/16Quest Diagnostics to Showcase Its Advanced Healthcare Information Technology Solutions at HIMSS16 Under its New Quanum™ Brand
The Quanum suite of healthcare information and technology solutions, based on Quest's industry leading dataset of 20 billion test results and national connectivity, help deliver better care and outcomes at lower costs MADISON, N.J., Feb. 22, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it will showcase its Quanum™ suite of healthcare information technology (HIT) solutions, including Data Diagnostics with... 
Printer Friendly Version
02/19/16Quest Diagnostics Named One of 2016 "World's Most Admired Companies" by Fortune Magazine
MADISON, N.J., Feb. 19, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named one of the "World's Most Admired Companies" for 2016 by Fortune.  The annual Fortune "World's Most Admired Companies" survey ranked Quest Diagnostics third among 10 companies in the "Health Care: Pharmacy and Other Services" industry, a jump of two places from last year. Quest ranked in the top three in all of th... 
Printer Friendly Version
01/28/16Quest Diagnostics Reports Fourth Quarter And Full Year 2015 Financial Results; Provides Guidance For Full Year 2016; Increases Dividend 5% To $0.40 Per Quarter
-- Full year revenues grew 2% on an equivalent basis and 0.8% on a reported basis -- Full year adjusted diluted EPS excluding amortization of $4.77, up 6% versus prior year -- Full year reported diluted EPS of $4.87, up 29% versus prior year -- Fourth quarter revenues grew 0.6% on an equivalent basis versus 2014; down 1.8% on a reported basis versus 2014 -- Fourth quarter adjusted diluted EPS excluding amortization of $1.19, up 0.8% versus prior year -- Fourth quarter reported dil... 
Printer Friendly Version
01/25/16Quest Diagnostics Expands Dako's PD-L1 IHC 28-8 Complementary Test to Include Melanoma
Third offering in Quest's precision medicine menu for oncology immunotherapies MADISON, N.J., Jan. 25, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it will offer clinical laboratory testing using the PD-L1 IHC 28-8 pharmDx qualitative test from Dako, an Agilent Technologies company. Earlier today, Dako announced the U.S. Food and Drug Administration (FDA) approved the complementary in vitro diagnostic te... 
Printer Friendly Version
01/15/16Quest Diagnostics To Release Fourth Quarter And Full Year 2015 Financial Results On January 28
MADISON, N.J., Jan. 15, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2015 results on Thursday, January 28, 2016, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can be accessed in listen-only mode by dialing 415-228-4961, passcode 3214469.... 
Printer Friendly Version
01/04/16Quest Diagnostics To Speak At The 34th Annual J.P. Morgan Healthcare Conference
MADISON, N.J., Jan. 4, 2016 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco. Steve Rusckowski, the company's President and CEO, will discuss the company's vision, goals and five point strategy. The presentation is scheduled for Tuesday, January 12, 2016 at 7:30 p.m. Eastern Time. The presentation will be we... 
Printer Friendly Version